Recent Study: Gastrointestinal Disorder Therapeutics to 2016

June 25, 2010 - PRLog -- GBI Research's report, "Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets", provides in-depth analysis of the unmet needs, drivers and barriers that affect the global gastrointestinal disorder therapeutics market. It analyzes the markets for gastrointestinal disorder therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

GBI Research finds that the gastrointestinal disorder therapeutics market will decline during the period 2009-2016. This decline is primarily driven by the negative growth of gastroesophageal reflux disease (GERD) therapeutics market which is attributed to loss of drug patents and entry of generics. However, other key gastrointestinal disorders such as crohn's disease and irritable bowels syndrome therapeutics market will continue to grow due to strong late stage pipeline that will address the unmet needs. The global gastrointestinal disorder therapeutics market is a highly fragmented market and big players are facing stiff competition. The forthcoming patent expiries of major drugs have increased the competition, driving the consolidation further. The increasing pressure has also driven companies to enter into licensing agreements. This allows companies to expand product portfolio and improve their competitive positions in the market.    

Scope

The scope of this report includes:

* Annualized market data for the gastrointestinal disorder therapeutics market from 2001 to 2009, forecast forward to 2016
* Analysis of the leading therapeutic segments. These include crohn's disease, ulcerative colitis, irritable bowel syndrome, and gastroesophageal reflux disease.
* Analysis of the gastrointestinal disorder therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
* Market characterization of the gastrointestinal disorder therapeutics market including market size, annual cost of therapy, and treatment usage patterns
* Key drivers and barriers that have a significant impact on the market
* Coverage of pipeline molecules in various phases of drug development
* Competitive benchmarking of leading companies. The key companies studied in this report are AstraZeneca, Takeda pharmaceutical company Ltd., Eisai pharmaceuticals Nycomed, Pfizer Inc, GlaxoSmithKline, Novartis AG, and Johnson & Johnson.
* Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global gastrointestinal disorder therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to

* Align product portfolio to the markets with high growth potential
* Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
* Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
* Develop key strategic initiatives by understanding key focus areas of leading companies
* Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps "

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/71131_gastrointestinal_disorde...

Partial Table of Contents:

2 Table of Contents
1 Executive Summary 1
2 Table of Contents 3
2.1 List of Tables 8
2.2 List of Figures 11
3 Global Gastrointestinal Disorder Therapeutics Market: Scope of Research 13
3.1 Introduction 13
3.2 GBI Research Report Guidance 13
4 Global Gastrointestinal Disorder Therapeutics Market: Market Characterization 14
4.1 Market Forecasts 14
4.2 Annual Cost of Treatment 15
4.3 Usage Patterns 16
4.3.1 Diseased Population 16
4.3.2 Treatment Seeking Population 17
4.3.3 Diagnosis Population 18
4.3.4 Prescription Population 19
4.3.5 Threapy Usage Patterns 20
4.3.6 Geographical Distribution 21
5 Global Gastrointestinal Disorder Therapeutics Market: US Market 22
5.1 Market Overview 22
5.2 Market Forecasts 22
5.3 Annual Cost of Treatment 23
5.4 Usage Patterns 24
5.4.1 Diseased Population 24
5.4.2 Treatment Seeking Population 25
5.4.3 Diagnosis Population 26
5.4.4 Prescription Population 27
5.4.5 Threapy Usage Patterns 28
6 Global Gastrointestinal Disorder Therapeutics Market: European Market 30
6.1 Market Overview 30
6.2 Market Forecasts 30
6.3 Annual Cost of Treatment 31
6.4 Usage Patterns 32
6.4.1 Diseased Population 32
6.4.2 Treatment Seeking Population 33
6.4.3 Diagnosis Population 34
6.4.4 Prescription Population 35
6.4.5 Therapy Usage Patterns 36
7 Global Gastrointestinal Disorder Therapeutics Market : Japan Market 38
7.1 Market Overview 38
7.2 Market Forecasts 38
7.3 Annual Cost of Treatment 39
7.4 Usage Patterns 40
7.4.1 Diseased Population 40
7.4.2 Treatment Seeking Population 41
7.4.3 Diagnosis Population 42
7.4.4 Prescription Population 43
7.4.5 Therapy Usage Patterns 44
8 Global Irritable Bowel Syndrome Therapeutics Market 46
8.1 Market Overview 46
8.2 Market Forecasts 46

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=7113...

About GBI Research

GBI Research provides industry-leading global business intelligence solutions. Their products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports each year across a wide range of industries. These reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from their expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia.  View more research from GBI Research at http://www.fastmr.com/catalog/publishers.aspx?pubid=1016

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.